Signal active
Contact Information
Social
Bio
Dr Boyd brings more than 20 years' experience in therapeutic antibody target discovery to OBT. He joined OBT from the MRC Toxicology Unit where as a senior investigator he identified novel lymphoma targets. He was previously head of proteome biology at Oxford Glycosciences where he led its oncology target discovery team. Dr Boyd holds a PhD in Biochemistry from Sussex University and conducted post-doctoral research at the Royal Postgraduate Medical School and the Imperial Cancer Research Fund.
Location
Oxford, Oxfordshire, United Kingdom, Europe
Jobs history
1
MiroBio
Senior Director, Preclinical Development
2019 - Current
Educations
1
N/A
Profile Resume
Robert Boyd is the Senior Director, Preclinical Development at MiroBio, based in Europe. With a background in Biotechnology, Robert Boyd has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.